Cargando…

The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission

Growing evidence indicates that the glucagon-like peptide-1 (GLP-1) system is involved in the neurobiology of addictive behaviors, and GLP-1 analogues may be used for the treatment of alcohol use disorder (AUD). Here, we examined the effects of semaglutide, a long-acting GLP-1 analogue, on biobehavi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chuong, Vicky, Farokhnia, Mehdi, Khom, Sophia, Pince, Claire L., Elvig, Sophie K., Vlkolinsky, Roman, Marchette, Renata C.N., Koob, George F., Roberto, Marisa, Vendruscolo, Leandro F., Leggio, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371247/ https://www.ncbi.nlm.nih.gov/pubmed/37192005 http://dx.doi.org/10.1172/jci.insight.170671

Ejemplares similares

Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
por: Williams, David M., et al.
Publicado: (2020)

Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies
por: Williams, David M., et al.
Publicado: (2021)

Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide
por: Basalay, Maryna V., et al.
Publicado: (2019)

Extended access to fentanyl vapor self-administration leads to addiction-like behaviors in mice: Blood chemokine/cytokine levels as potential biomarkers
por: Marchette, Renata C.N., et al.
Publicado: (2023)

Advances in GLP-1 treatment: focus on oral semaglutide
por: Eliaschewitz, Freddy G., et al.
Publicado: (2021)

Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality?
por: Basalay, Maryna V., et al.
Publicado: (2020)

Glucagon, GLP-1 and Thermogenesis
por: González-García, Ismael, et al.
Publicado: (2019)

Alcohol Dependence Induces CRF Sensitivity in Female Central Amygdala GABA Synapses
por: Rodriguez, Larry, et al.
Publicado: (2022)

Glucagon-like peptide 1 (GLP-1)
por: Müller, T.D., et al.
Publicado: (2019)

Anxiety disorders and GABA neurotransmission: a disturbance of modulation
por: Nuss, Philippe
Publicado: (2015)

Astrocytic GABA transporter activity modulates excitatory neurotransmission
por: Boddum, Kim, et al.
Publicado: (2016)

Effect of Various Dosing Conditions on the Pharmacokinetics of Oral Semaglutide, a Human Glucagon-Like Peptide-1 Analogue in a Tablet Formulation
por: Bækdal, Tine A., et al.
Publicado: (2021)

Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats
por: Marty, Vincent N., et al.
Publicado: (2020)

Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
por: Vecera, Courtney M., et al.
Publicado: (2023)

Genetic or pharmacological GHSR blockade has sexually dimorphic effects in rodents on a high-fat diet
por: Leggio, Lorenzo, et al.
Publicado: (2023)

κ-Opioid receptor antagonism reverses heroin withdrawal-induced hyperalgesia in male and female rats
por: Marchette, Renata C.N., et al.
Publicado: (2021)

Counselling Patients for GLP-1 Analogue Therapy: Comparing GLP-1 Analogue with Insulin Counselling
por: Kalra, Sanjay, et al.
Publicado: (2012)

PD-1 Regulates GABAergic Neurotransmission and GABA-Mediated Analgesia and Anesthesia
por: Jiang, Changyu, et al.
Publicado: (2020)

Fluoxetine Suppresses Glutamate- and GABA-Mediated Neurotransmission by Altering SNARE Complex
por: Lazarevic, Vesna, et al.
Publicado: (2019)

Oxytocin blocks enhanced motivation for alcohol in alcohol dependence and blocks alcohol effects on GABAergic transmission in the central amygdala
por: Tunstall, Brendan J., et al.
Publicado: (2019)

Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes
por: Raven, Lisa M, et al.
Publicado: (2022)

Absence of QTc Prolongation with Sodium N-(8-[2-Hydroxybenzoyl] Amino) Caprylate (SNAC), an Absorption Enhancer Co-Formulated with the GLP-1 Analogue Semaglutide for Oral Administration
por: Granhall, Charlotte, et al.
Publicado: (2021)

Benzodiazepines modulate GABA(A )receptors by reducing a gamma-subunit-mediated inhibition of GABA sensitivity
por: Baburin, Igor, et al.
Publicado: (2009)

Serum levels of glucagon-like peptide (GLP)-1 and GLP-2 in patients with Hashimoto's thyroiditis
por: Jin, Yue, et al.
Publicado: (2015)

Plasma levels of glucagon but not GLP-1 are elevated in response to inflammation in humans
por: Modrzynska, Justyna, et al.
Publicado: (2021)

Enhanced BDNF and TrkB Activation Enhance GABA Neurotransmission in Cerebellum in Hyperammonemia
por: Arenas, Yaiza M., et al.
Publicado: (2022)

Correction to “Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes”
Publicado: (2022)

GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017)

Differential association between the GLP1R gene variants and brain functional connectivity according to the severity of alcohol use
por: Farokhnia, Mehdi, et al.
Publicado: (2022)

A deeper insight into how GABA-B receptor agonism via baclofen may affect alcohol seeking and consumption: Lessons learned from a human laboratory investigation
por: Farokhnia, Mehdi, et al.
Publicado: (2018)

Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide
por: McLean, Brent A., et al.
Publicado: (2021)

Successful treatment of binge eating disorder with the GLP-1 agonist semaglutide: A retrospective cohort study
por: Richards, Jesse, et al.
Publicado: (2023)

Fentanyl vapor self-administration model in mice to study opioid addiction
por: Moussawi, K., et al.
Publicado: (2020)

Assessment of Glucagon-Like Peptide-1 Analogue and Renin Inhibitor on the Binding and Regulation of GLP-1 Receptor in Type 1 Diabetic Rat Hearts
por: Artinian, Shushan B., et al.
Publicado: (2011)

Calpain Cleavage of Brain Glutamic Acid Decarboxylase 65 Is Pathological and Impairs GABA Neurotransmission
por: Buddhala, Chandana, et al.
Publicado: (2012)

Prefrontal cortical alterations of glutamate and GABA neurotransmission in schizophrenia: Insights for rational biomarker development
por: Schoonover, Kirsten E., et al.
Publicado: (2020)

TGF-β/Smad3 Signalling Modulates GABA Neurotransmission: Implications in Parkinson’s Disease
por: Muñoz, Mª Dolores, et al.
Publicado: (2020)

Future perspectives in diabesity treatment: Semaglutide, a glucagon-like peptide 1 receptor agonist (Review)
por: Tilinca, Mariana Cornelia, et al.
Publicado: (2021)

Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9–36 Amide at the GLP-1 Receptor
por: Li, Naichang, et al.
Publicado: (2012)

Nutritional Ketosis as a Potential Treatment for Alcohol Use Disorder
por: Mahajan, Vikrant R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ct26mvigf9simn9lhqqfpv419